We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
ISSCR 2026
Automated iPSC-derived Islet Organoids Platform for Population-scale Modeling of Type 2 Diabetes

Automated iPSC-derived Islet Organoids Platform for Population-scale Modeling of Type 2 Diabetes

Published Date July 8, 2026

Loading, please wait

Error - something went wrong!

Register to Attend our Innovation Showcase

Thank you! We will be in touch soon.

Previous Flipbook

High-Throughput Genome Editing and Quality Control of Human iPSC Lines for Large Scale Disease Modeling
Next Flipbook

A Scalable and Reversible Strategy to Knock Out Gene Function in Human Induced Pluripotent Stem Cells

Other content in this Stream

3 days ago
High-Throughput Expansion and Banking of iPSC Lines Using the JAX-NYSCF Automated Platform

Read More
3 days ago
High-Throughput Genome Editing and Quality Control of Human iPSC Lines for Large Scale Disease Modeling

Read More
3 days ago
A Scalable and Reversible Strategy to Knock Out Gene Function in Human Induced Pluripotent Stem Cells

Read More
3 days ago
Development Approach to Modeling Intracranial Germ Cell Tumors Using Human Pluripotent Stem Cells

Read More
3 days ago
Mapping RPE-to-Photoreceptor Programming for Stem Cell Therapy

Read More
3 days ago
Natural Genetic Variation Reveals Loci Controling Differentiation Propensity and Lineage Specification in Mouse Embryonic Stem Cells

Read More
3 days ago
Diverse Embryonic Stem Cells Reveal Coevolved Genome Regulatory Incompatibilities Affecting Viability and Fertility

Read More
23 days ago
The JAX-NYSCF Global Stem Cell Array®️

Automated platform to generate high-quality induced iPSC lines and differentiate them into diverse, disease-relevant cell types. Advanced capabilities for efficient, reproducible research.

Read More
about 1 month ago
Partner with JAX-NYSCF

Learn more about the JAX-NYSCF partnership to accelerate cures for the major diseases of our time through stem cell research, from large iPSC cohorts for specific disease areas to developing...

Read More
about 1 month ago
Powering Discovery with JAX iPSC Models

View highlights and comparison of JAX genetically engineered isogenic iPSC and donor-derived, disease-specific iPSC lines.

Read More
8 months ago
Engineered vs. Patient-Derived iPSCs: Strengths, Limitations, and Applications

Induced pluripotent stem cells (iPSCs) have become a cornerstone of modern biomedical research, offering unprecedented opportunities to model human development, investigate disease mechanisms, and...

Learn More
about 1 year ago
Why Clonal iPSC Lines Are Essential: Building a Foundation for Reliable and Reproducible Research

Induced pluripotent stem cells (iPSCs) have become indispensable tools in modern biomedical research and are transforming how we model human disease, discover drugs, and explore regenerative...

Learn More
11 months ago
Defining a Reference iPSC Line: Criteria, Context, and the Case of KOLF2.1J

In the field of stem cell research, the quest to define a “reference” induced pluripotent stem cell (iPSC) line is ongoing and nuanced. As we deepen our understanding of human biology, one thing...

Learn More
10 months ago
From iPSCs to Microglia in Record Time: A Xeno-Free, Tet-Inducible Differentiation Protocol Using KOLF2.1J.

In this webinar, Dr. Oliveira will introduce JAX’s new Tet-inducible neuron and microglia human induced pluripotent stem cell (hiPSCs) lines.

Watch Video
4 months ago
Tools with a Mission: Using Disease Models to Find a Treatment for PURA Syndrome

This webinar explores the urgent need for innovative models and highlights JAX’s development of iPSC lines to advance understanding of PURA syndrome and enable drug discovery.

Watch Video
5 months ago
MorPhiC: Decoding Human Protein-Coding Gene Function at Scale in iPSC-Derived Multicellular Systems

Learn about the MorPhiC Consortium and its initiative to generate a comprehensive catalog of molecular and cellular phenotypes for null alleles of every human protein-coding gene.

Watch Video
6 months ago
JAX Tech Talk Episode 68: Let’s Talk iPSC Disease Models as a Tool in Drug Discovery (Nov. 7, 2023)

During this JAX Tech Talk, Dr. Steven Rodriguez, Lab Head of the Rare & Neurological Diseases Therapeutic Area at Sanofi, discusses how his group uses iPSC models to understand disease biology.

Watch Video
6 months ago
JAX Tech Talk Episode 59: Let’s Talk iPSCs and Their Value in Tackling Neurodegenerative Diseases (Sep. 20, 2022)

Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.

Watch Video

Return to Home

© The Jackson Laboratory